CBL496
Anti-CD34 Class II Antibody, clone QBEND/10
clone QBEND/10, Chemicon®, from mouse
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
100
300
antibody form
purified antibody
antibody product type
primary antibodies
clone
QBEND/10, monoclonal
species reactivity
monkey, human
packaging
antibody small pack of 25 μg
manufacturer/tradename
Chemicon®
technique(s)
flow cytometry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
immunoprecipitation (IP): suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
Gene Information
human ... CD34(947)
Related Categories
Specificity
The antibody recognizes a heavily glycosylated transmembrane protein: gp 105-120 kDa. The antigen is expressed on immature human haemopoietic precursor cells, capillary endothelial cells and human myeloid cells in the following categories: subsets of CFU-GEMM and BFU-E, all CFU-GM, granulocyte precursors, monocytes, myeloid leukaemias. This antibody recognizes the class II epitope showing resistance to neuraminidase enzyme cleavage.
KNOWN SPECIES CROSS REACTIVITY: Positive with rhesus monkey peripheral blood leucocytes in flow cytometry.
FUSION PARTNER: NSO myeloma cell line
KNOWN SPECIES CROSS REACTIVITY: Positive with rhesus monkey peripheral blood leucocytes in flow cytometry.
FUSION PARTNER: NSO myeloma cell line
Immunogen
Human endothelial vesicles
Application
Anti-CD34 Antibody, Class II, clone QBEND/10 is an antibody against CD34 Class II for use in FC, IP, IH, IH(P).
Identification of haemopoietic progenitor cells
Studies into the control mechanisms of early haemopoiesis
Purification of haemopoietic cells from, for example, FACS
The antibody reacts with both frozen and fixed tissue sections from vascular endothelium and stromal fibroblasts
Immunohistochemistry in parraffin sections: Pretreatment is HIER with citrate buffer, pH 6.0.
Optimal working dilutions must be determined by the end user.
Studies into the control mechanisms of early haemopoiesis
Purification of haemopoietic cells from, for example, FACS
The antibody reacts with both frozen and fixed tissue sections from vascular endothelium and stromal fibroblasts
Immunohistochemistry in parraffin sections: Pretreatment is HIER with citrate buffer, pH 6.0.
Optimal working dilutions must be determined by the end user.
Research Category
Inflammation & Immunology
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology
Immunoglobulins & Immunology
Quality
Tested
Physical form
Format: Purified
The monoclonal is presented at a concentration of 100μg/1ml in phosphate buffered saline containing 10mM sodium azide and 1mg/ml bovine serum albumin. We recommend that each laboratory determine an optimum working titre for use in its particular application.
Storage and Stability
For use within 1 month of purchase store at +4°C, for long term storage aliquot antibody into small volumes and store at -20°C.
Other Notes
Please refer to lot specific datasheet.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
recommended
Product No.
Description
Pricing
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Matthew D Wood et al.
Journal of neuropathology and experimental neurology, 75(10), 925-935 (2016-08-20)
Glioblastomas (GBM) are aggressive brain tumors that inevitably recur despite surgical resection, chemotherapy, and radiation. The degree to which recurrent GBM retains its initial immunophenotype is incompletely understood. We generated tissue microarrays of paired initial and posttreatment GBM (3 pairs
The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.
C E de Bock,A Ardjmand,T J Molloy,S M Bone,D Johnstone,D M Campbell,K L Shipman et al.
Leukemia null
Aisulu Usubalieva et al.
Journal of neuropathology and experimental neurology, 74(10), 960-969 (2015-09-10)
Primary meningeal gliomas are rare tumors composed of a heterogeneous group of neoplasms. We present 2 clinically aggressive cases of primary meningeal pleomorphic xanthoastrocytoma that clinically mimicked meningioma. One case presented in the posterior fossa of a 56-year-old woman; the
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
Engler, JR; Robinson, AE; Smirnov, I; Hodgson, JG; Berger, MS; Gupta, N; James et al.
Testing null
Yijie Geng et al.
Heliyon, 2(7), e00133-e00133 (2016-08-12)
The emerging models of human embryonic stem cell (hESC) self-organizing organoids provide a valuable in vitro platform for studying self-organizing processes that presumably mimic in vivo human developmental events. Here we report that through a chemical screen, we identified two
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service